New Biomarkers for Better Neurodegenerative Disease Diagnostics and Treatments
Russ Lebovitz, MD, PhD
Better diagnostics for neurodegenerative diseases can improve clinical trials to help move groundbreaking therapies to approval
Parkinson's disease
Screening for Skin-Based Biomarker Helps Diagnose Parkinson’s
Beth Israel Deaconess Medical Center
Simple test detects the key biomarker in neurodegenerative diseases that could lead to earlier diagnosis and accelerate drug development
MS Biomarker Test Gets Breakthrough Device Designation
Swathi Kodaikal, MSc
Blood NfL levels can provide insights into neurological conditions such as Alzheimer’s, Parkison’s, and Huntington’s diseases
Novel Blood Biomarker Identifies Parkinsonian Diseases Early On
Lund University
DOPA decarboxylase was found elevated many years before individuals developed Parkinson’s symptoms
New Roles of Genes Driving Parkinson’s Onset Discovered
Northwestern University
Scientists report that damage starts much earlier than the death of dopamine neurons
New Blood Biomarker Aids Early Detection of Parkinson’s
Duke Health
Blood test accurately detects certain genetic mutations in the mitochondrial DNA of patients with Parkinson’s
PD Patient Receives First-Ever Stem Cell-Based Transplant
Lund University
Transplant replaces dopaminergic neurons, which are degenerated in patients with Parkinson’s disease
Preliminary Form of Parkinson’s Indicator in Stool Sample
Heinrich Heine University Düsseldorf
Isolated REM sleep behavior and gut-brain axis may also help study Parkinson’s disease
Diagnosis of Early-Stage Parkinson’s Disease Now Possible with New Method
The Hebrew University of Jerusalem
This type of analysis could also lead to more personalized treatments
A Biomarker That Can Diagnose Parkinson’s Disease
Kobe University
It is hoped that being able to diagnose the disease faster will also lead to the development of new treatment methods